Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2025-11-14 20:08 2025-11-13 AORT Artivion Inc. Holloway Jean F Officer SELL $45.86 5,761 $264,188 163,408
2025-11-15 03:48 2025-11-12 SGHT Sight Sciences, Inc. HAYDEN JEREMY B. Officer OPT+S $8.01 3,150 $25,232 256,590
2025-11-14 20:09 2025-11-13 AORT Artivion Inc. Mackin James P Officer SELL $45.86 34,210 $1,568,802 800,993
2025-11-14 22:28 2025-11-13 AORT Artivion Inc. Horton Amy Officer SELL $45.86 3,482 $159,678 141,380
2025-11-15 00:33 2025-11-12 ATEC Alphatec Holdings, Inc. Squadron Capital LLC 10% owner SELL $20.80 250,000 $5,200,000 11,145,045
2025-11-15 00:36 2025-11-12 ATEC Alphatec Holdings, Inc. Pelizzon David R Director, 10% owner SELL $20.80 250,000 $5,200,000 11,145,045
2025-11-15 01:20 2025-11-12 ATEC Alphatec Holdings, Inc. Squadron Capital Holdings LLC 10% owner SELL $20.80 250,000 $5,200,000 11,145,045
2025-11-15 01:12 2025-11-12 ATEC Alphatec Holdings, Inc. Pritzker Jennifer N. 10% owner SELL $20.80 250,000 $5,200,000 11,145,045
2025-11-14 23:07 2025-11-12 CVRX CVRx, Inc. JOHNSON & JOHNSON 10% owner SELL $10.00 1,000 $10,000 4,049,898
2025-11-14 01:24 2025-11-11 RMD RESMED INC De Witte Jan Director SELL $250.25 487 $121,872 5,319
2025-11-13 17:06 2025-11-11 SRTS Sensus Healthcare, Inc. Sardano Michael Director, Officer BUY $4.26 2,000 $8,523 118,839
2025-11-14 00:31 2025-11-11 SIBN SI-BONE, Inc. Maheshwari Anshul Officer SELL $18.33 2,601 $47,685 208,533
2025-11-14 00:05 2025-11-12 NSPR InspireMD, Inc. Stuka Paul Director BUY $1.62 13,431 $21,758 373,715
2025-11-14 01:12 2025-11-12 GMED GLOBUS MEDICAL INC Davidar David D Director OPT+S $86.00 25,000 $2,150,005 516,275
2025-11-13 19:53 2025-11-11 DCTH DELCATH SYSTEMS, INC. MICHEL GERARD J Director, Officer BUY $8.53 11,500 $98,049 330,834
2025-11-14 00:31 2025-11-11 SIBN SI-BONE, Inc. FRANCIS LAURA Director, Officer SELL $17.06 5,411 $92,307 356,730
2025-11-14 01:06 2025-11-11 GMED GLOBUS MEDICAL INC ZARRILLI STEPHEN T Director OPT+S $84.29 25,000 $2,107,258 0
2025-11-14 01:39 2025-11-12 RMD RESMED INC FARRELL PETER C Director SELL $252.05 2,000 $504,100 66,110
2025-11-13 21:29 2025-11-11 RVP RETRACTABLE TECHNOLOGIES INC SHAW THOMAS J Director, Officer, 10% owner BUY $0.81 100 $81 15,825,491
2025-11-14 01:07 2025-11-11 LYRA Lyra Therapeutics, Inc. PERCEPTIVE ADVISORS LLC 10% owner SELL $3.98 45,875 $182,514 14,026
2025-11-14 00:31 2025-11-11 SIBN SI-BONE, Inc. DUNN JEFFREY W Director OPT+S $18.95 80,000 $1,516,000 10,307
2025-11-13 04:05 2025-11-10 AORT Artivion Inc. Stanton Marshall S. Officer SELL $44.62 2,566 $114,492 61,634
2025-11-12 19:23 2025-11-06 UFPT UFP TECHNOLOGIES INC Litterio Christopher P. Officer SELL $227.20 1,829 $415,550 10,756
2025-11-12 18:55 2025-11-11 ICUI ICU MEDICAL INC/DE Sanzone Virginia Ruth Officer SELL $142.35 930 $132,381 5,456
2025-11-13 04:07 2025-11-10 AORT Artivion Inc. Davis John E Officer SELL $44.62 3,373 $150,500 205,405
2025-11-13 04:12 2025-11-10 AORT Artivion Inc. Holloway Jean F Officer OPT+S $45.82 12,960 $593,873 169,169
2025-11-12 17:53 2025-11-11 SRTS Sensus Healthcare, Inc. Sardano Michael Director, Officer BUY $4.26 1,000 $4,260 117,839
2025-11-13 04:08 2025-11-10 AORT Artivion Inc. Mackin James P Officer SELL $44.62 17,580 $784,402 835,203
2025-11-13 04:06 2025-11-10 AORT Artivion Inc. Horton Amy Officer SELL $44.62 1,789 $79,823 144,862
2025-11-13 00:00 2025-11-10 IRMD IRADIMED CORP Susi Roger E. Director, Officer, 10% owner SELL $85.24 5,000 $426,193 2,317,500
2025-11-13 03:32 2025-11-10 PEN Penumbra Inc Roberts Johanna Officer SELL $266.98 600 $160,189 63,657
2025-11-13 00:33 2025-11-10 IRTC iRhythm Holdings, Inc. TALWALKAR ABHIJIT Y Director OPT+S $174.13 5,312 $924,962 20,299
2025-11-13 00:18 2025-11-10 HAE HAEMONETICS CORP KROLL MARK W Director BUY $70.56 1,400 $98,784 24,757
2025-11-13 00:00 2025-11-10 IRMD IRADIMED CORP GLENN JOHN Officer SELL $84.51 10,651 $900,162 2,500
2025-11-12 18:59 2025-11-11 ICUI ICU MEDICAL INC/DE FINNEY ELISHA W Director OPT+S $140.42 1,285 $180,440 3,995
2025-11-13 01:14 2025-11-12 DXCM DEXCOM INC Heller Bridgette P Director SELL $58.07 1,012 $58,767 27,031
2025-11-11 01:08 2025-11-07 BVS Bioventus Inc. McMurry-Heath Michelle Director SELL $7.42 17,701 $131,255 56,997
2025-11-11 03:07 2025-11-07 RMD RESMED INC Farrell Michael J. Director, Officer OPT+S $249.75 8,011 $2,000,773 467,866
2025-11-11 01:14 2025-11-06 MDXG MIMEDX GROUP, INC. Maersk-Moller Kimberly Officer SELL $7.42 58,300 $432,329 236,982
2025-11-10 16:00 2025-11-07 SINT Sintx Technologies, Inc. Honigblum Gregg R. Director, Officer BUY $3.19 10,000 $31,900 74,000
2025-11-11 00:15 2025-11-07 GMED GLOBUS MEDICAL INC RHOADS ANN D Director SELL $81.80 10,000 $818,000 15,384
2025-11-10 23:28 2025-11-06 CVRX CVRx, Inc. JOHNSON & JOHNSON 10% owner SELL $10.21 52,532 $536,310 4,050,898
2025-11-11 01:08 2025-11-06 LYRA Lyra Therapeutics, Inc. PERCEPTIVE ADVISORS LLC 10% owner SELL $4.89 70,390 $344,221 18,659
2025-11-11 03:13 2025-11-10 DXCM DEXCOM INC Leach Jacob Steven Officer BUY $55.04 18,200 $1,001,703 331,697
2025-11-11 03:12 2025-11-10 DXCM DEXCOM INC Collins Richard Alexander Director SELL $55.17 3,948 $217,811 37,994
2025-11-08 04:00 2025-11-06 NXGL NEXGEL, INC. Levy Adam R. Director, Officer SELL $2.52 4,000 $10,084 367,692
2025-11-08 00:22 2025-11-05 SYK STRYKER CORP STRYKER RONDA E Director SELL $355.01 520,000 $184,606,136 2,702,108
2025-11-08 01:36 2025-11-07 BDX BECTON DICKINSON & CO SCOTT BERTRAM L Director SELL $176.58 217 $38,318 35,816
2025-11-07 00:34 2025-11-06 BSX BOSTON SCIENTIFIC CORP Zane Ellen M Director SELL $98.28 12,891 $1,266,978 24,134
2025-11-07 03:31 2025-11-04 PEN Penumbra Inc Grewal Harpreet Director SELL $227.58 186 $42,330 8,516
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.